Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alegre-Sancho JJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    Relationship between trabecular bone score, bone mineral density and vertebral fractures in patients with axial spondyloarthritis.
    Autorzy:
    Valls-Pascual E; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain. .
    Orenes-Vera AV; Rheumatology Department, Arnau de Vilanova University Hospital, Valencia, Spain.
    Sendra-García A; Pharmacy Department, Doctor Peset University Hospital, Valencia, Spain.
    Martínez-Ferrer À; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain.
    Montolío-Chiva L; Rheumatology Department, University General Hospital of Castellón, Castellón de La Plana, Spain.
    Vázquez-Gómez I; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain.
    Flores-Fernández E; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain.
    Ybáñez-García D; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain.
    Vega-Martínez M; Radiology Department, Doctor Peset University Hospital, Valencia, Spain.
    García-Ferrer L; Radiology Department, Doctor Peset University Hospital, Valencia, Spain.
    Graells-Ferrer M; Radiology Department, Doctor Peset University Hospital, Valencia, Spain.
    Alegre-Sancho JJ; Rheumatology Department, Doctor Peset University Hospital, Valencia, Spain.
    Pokaż więcej
    Źródło:
    BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 Apr 22; Vol. 24 (1), pp. 316. Date of Electronic Publication: 2023 Apr 22.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Spinal Fractures*/diagnostic imaging
    Spinal Fractures*/epidemiology
    Spinal Fractures*/etiology
    Axial Spondyloarthritis*
    Osteoporotic Fractures*/epidemiology
    Male ; Humans ; Female ; Middle Aged ; Bone Density ; Absorptiometry, Photon ; Cancellous Bone/diagnostic imaging ; Cross-Sectional Studies ; C-Reactive Protein/metabolism ; Lumbar Vertebrae/diagnostic imaging ; Lumbar Vertebrae/injuries
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The Role of Plasma Calprotectin in Non-infectious Uveitis.
    Autorzy:
    Pascual EV; Department of Rheumatology, Hospital Universitari Doctor Peset, Valencia, Spain.; Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
    Martínez-Costa Pérez L; Department of Ophthalmology, Hospital Universitari Doctor Peset, Valencia, Spain.
    Hernández Pons A; Department of Ophthalmology, Hospital Universitari Doctor Peset, Valencia, Spain.
    López Ortega JM; Department of Clinical Analysis, Hospital Universitari Doctor Peset, Valencia, Spain.
    Grau García E; Department of Rheumatology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
    Albert Fort M; Department of Ophthalmology, Hospital Universitari Doctor Peset, Valencia, Spain.
    Alegre Sancho JJ; Department of Rheumatology, Hospital Universitari Doctor Peset, Valencia, Spain.
    Ivorra JAR; Department of Rheumatology, Hospital Universitari I Politècnic La Fe, Valencia, Spain.; Facultad de Medicina y Odontologia, Universidad Catolica de Valencia San Vicente Martir, Valencia, Spain.
    Pokaż więcej
    Źródło:
    Current eye research [Curr Eye Res] 2021 Aug; Vol. 46 (8), pp. 1184-1192. Date of Electronic Publication: 2021 Jan 11.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Biomarkers/*blood
    Leukocyte L1 Antigen Complex/*blood
    Uveitis/*blood
    Adult ; Aged ; Aging/physiology ; Cross-Sectional Studies ; Female ; Fluorescein Angiography ; Humans ; Male ; Middle Aged ; Prospective Studies ; Slit Lamp Microscopy ; Tomography, Optical Coherence ; Uveitis/diagnosis ; Visual Acuity/physiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    Autorzy:
    Ferreiro-Iglesias A; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
    Montes A; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
    Perez-Pampin E; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
    Cañete JD; Arthritis Unit, Rheumatology Dpt, Hospital Clinic and IDIBAPS, Barcelona, Spain.
    Raya E; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.
    Magro-Checa C; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
    Vasilopoulos Y; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
    Caliz R; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
    Ferrer MA; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
    Joven B; Reumatology Department, Hospital 12 de Octubre, Madrid, Spain.
    Carreira P; Reumatology Department, Hospital 12 de Octubre, Madrid, Spain.
    Balsa A; Department of Rheumatology, Instituto de Investigación Hospital Universitario La Paz, Hospital Universitario La Paz, Madrid, Spain.
    Pascual-Salcedo D; Department of Immunology, Instituto de Investigación Hospital Universitario La Paz, Madrid, Spain.
    Blanco FJ; Rheumatology Department, Instituto de Investigacion Biomedica-Complejo Hospitalario Universitario A Coruna, A Coruna, Spain.
    Moreno-Ramos MJ; Department of Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain.
    Manrique-Arija S; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
    Ordoñez MDC; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
    Alegre-Sancho JJ; Department of Rheumatology, Hospital Doctor Peset, Valencia, Spain.
    Narvaez J; Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain.
    Navarro-Sarabia F; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
    Moreira V; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
    Valor L; Rheumatology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    Garcia-Portales R; Department of Rheumatology, Hospital Virgen de la Victoria, Málaga, Spain.
    Marquez A; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
    Gomez-Reino JJ; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
    Martin J; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
    Gonzalez A; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigacion Sanitaria-Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Feb 28; Vol. 14 (2), pp. e0213073. Date of Electronic Publication: 2019 Feb 28 (Print Publication: 2019).
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Polymorphism, Single Nucleotide*
    Arthritis, Rheumatoid/*drug therapy
    Arthritis, Rheumatoid/*genetics
    Etanercept/*therapeutic use
    Tumor Necrosis Factor-alpha/*antagonists & inhibitors
    Adult ; Aged ; Aged, 80 and over ; Antirheumatic Agents/therapeutic use ; Female ; Genetic Markers ; Genome-Wide Association Study ; Humans ; Male ; Middle Aged ; Pharmacogenomic Testing ; Pharmacogenomic Variants ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Behçet's disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes.
    Autorzy:
    Burillo-Sanz S; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Montes-Cano MA; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    García-Lozano JR; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Olivas-Martínez I; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Ortego-Centeno N; Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, 18003, Spain.
    García-Hernández FJ; Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, 41003, Spain.
    Espinosa G; Department Autoimmune Diseases, Hospital Clinic Universitari, Barcelona, 08036, Spain.
    Graña-Gil G; Department of Rheumatology, Complejo Hospitalario Universitario, A Coruña, 15006, Spain.
    Sánchez-Bursón J; Department of Rheumatology, Hospital Universitario de Valme, Sevilla, 41014, Spain.
    Juliá MR; Department of Immunology, Hospital Universitari Son Espases, Palma de Mallorca, Illes Balears, 07120, Spain.
    Solans R; Department of Internal Medicine, Autoimmune Systemic Diseases Unit, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Barcelona, 08035, Spain.
    Blanco R; Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain.
    Barnosi-Marín AC; Department of Internal Medicine, Complejo Hospitalario Torrecárdenas, Almería, 04009, Spain.
    Gómez de la Torre R; Department of Internal Medicine, Hospital Universitario Central de Asturias, Asturias, 33011, Spain.
    Fanlo P; Department of Internal Medicine, Hospital Virgen del Camino, Pamplona, 31008, Spain.
    Rodríguez-Carballeira M; Deparment of Internal Medicine, Hospital Universitari Mútua Terrassa, Terrassa, 08221, Spain.
    Rodríguez-Rodríguez L; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, 28040, Spain.
    Camps T; Department of Internal Medicine, Hospital Regional Universitario, Málaga, 29010, Spain.
    Castañeda S; Department of Rheumatology, Hospital de la Princesa, IIS-Princesa, Madrid, 28006, Spain.
    Alegre-Sancho JJ; Department of Rheumatology, Hospital Universitario Doctor Peset, Valencia, 46017, Spain.
    Martín J; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS, Granada, 18016, Spain.
    González-Escribano MF; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Feb 26; Vol. 9 (1), pp. 2777. Date of Electronic Publication: 2019 Feb 26.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Epistasis, Genetic*
    Genetic Predisposition to Disease*
    Polymorphism, Genetic*
    Behcet Syndrome/*pathology
    HLA-B Antigens/*genetics
    Hereditary Autoinflammatory Diseases/*genetics
    Inflammation Mediators/*metabolism
    Adaptor Proteins, Signal Transducing/genetics ; Adult ; Behcet Syndrome/genetics ; Cohort Studies ; Cytoskeletal Proteins/genetics ; Female ; Genotype ; Humans ; Intracellular Signaling Peptides and Proteins/genetics ; Male ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics ; Pyrin/genetics ; Receptors, Tumor Necrosis Factor, Type I/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
    Autorzy:
    Lopez-Rodriguez R; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
    Perez-Pampin E; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
    Marquez A; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
    Blanco FJ; Rheumatology Department, Instituto de Investigacion Biomedica-Complejo Hospitalario Universitario A Coruna, Coruna, Spain.
    Joven B; Reumatology Department, Madrid, Spain.
    Carreira P; Reumatology Department, Madrid, Spain.
    Ferrer MA; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
    Caliz R; Rheumatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
    Valor L; Rheumatology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    Narvaez J; Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain.
    Cañete JD; Arthritis Unit, Rheumatology Dpt, Hospital Clinic and IDIBAPS, Barcelona, Spain.
    Ordoñez MDC; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga Spain.
    Manrique-Arija S; Servicio de Reumatología, HRU Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga Spain.
    Vasilopoulos Y; Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
    Balsa A; Rheumatology Unit, Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Hospital Universitario La Paz, Madrid, Spain.
    Pascual-Salcedo D; Department of Immunology, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.
    Moreno-Ramos MJ; Department of Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain.
    Alegre-Sancho JJ; Department of Rheumatology, Hospital Doctor Peset, Valencia, Spain.
    Navarro-Sarabia F; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
    Moreira V; Rheumatology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
    Garcia-Portales R; Department of Rheumatology, Hospital Virgen de la Victoria, Málaga, Spain.
    Raya E; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.
    Magro-Checa C; Department of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
    Martin J; Instituto de Parasitología y Biomedicina López-Neyra, CSIC, Granada, Spain.
    Gomez-Reino JJ; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
    Gonzalez A; Experimental and Observational Rheumatology and Rheumatology Unit, Instituto de Investigación Sanitaria, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 May 07; Vol. 13 (5), pp. e0196793. Date of Electronic Publication: 2018 May 07 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antirheumatic Agents/*therapeutic use
    Arthritis, Rheumatoid/*drug therapy
    Arthritis, Rheumatoid/*genetics
    Genetic Markers/*genetics
    Tumor Necrosis Factor-alpha/*antagonists & inhibitors
    Female ; Genotype ; Humans ; Male ; Middle Aged ; Reproducibility of Results
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study.
    Autorzy:
    Vergara-Dangond C; Department of Rheumatology, Doctor Peset University Hospital, Gaspar Aguilar Avenue 90, 46017, Valencia, Spain.
    Sáez Belló M; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
    Climente Martí M; Pharmacy Service, Doctor Peset University Hospital, Valencia, Spain.
    Llopis Salvia P; Pharmacy Service, Doctor Peset University Hospital, Valencia, Spain.
    Alegre-Sancho JJ; Department of Rheumatology, Doctor Peset University Hospital, Gaspar Aguilar Avenue 90, 46017, Valencia, Spain. alegre_.
    Pokaż więcej
    Źródło:
    Drugs in R&D [Drugs R D] 2017 Sep; Vol. 17 (3), pp. 481-485.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Antibodies, Monoclonal/*administration & dosage
    Antirheumatic Agents/*administration & dosage
    Biosimilar Pharmaceuticals/*administration & dosage
    Infliximab/*administration & dosage
    Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antirheumatic Agents/adverse effects ; Biosimilar Pharmaceuticals/adverse effects ; Female ; Humans ; Infliximab/adverse effects ; Male ; Middle Aged ; Remission Induction ; Retrospective Studies ; Rheumatic Diseases/drug therapy ; Rheumatic Diseases/physiopathology ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.
    Autorzy:
    López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Corrales A; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Vicente E; Rheumatology Department, Hospital Universitario la Princesa, IIS-IP, Madrid, Spain.
    Robustillo-Villarino M; Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
    González-Juanatey C; Cardiology Department, Hospital Lucus Augusti, Lugo, Spain.
    Llorca J; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
    Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Remuzgo-Martínez S; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Dierssen-Sotos T; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
    Miranda-Filloy JA; Division of Rheumatology, Hospital Universitario Lucus Augusti, Lugo, Spain.
    Huaranga MA; Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
    Pina T; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Alegre-Sancho JJ; Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
    Raya E; Rheumatology Department, Hospital Clínico San Cecilio, Granada, Spain.
    Mijares V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Ubilla B; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.
    Ferraz-Amaro I; Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
    Gómez-Vaquero C; Department of Rheumatology, Hospital Universitario Bellvitge, Barcelona, Spain.
    Balsa A; Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain.
    López-Longo FJ; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    Carreira P; Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
    González-Álvaro I; Rheumatology Department, Hospital Universitario la Princesa, IIS-IP, Madrid, Spain.
    Ocejo-Vinyals JG; Immunology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
    Rodríguez-Rodríguez L; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
    Fernández-Gutiérrez B; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
    Castañeda S; Rheumatology Department, Hospital Universitario la Princesa, IIS-IP, Madrid, Spain.
    Martín J; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS Granada, Granada, Spain.
    González-Gay MA; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Department, IDIVAL, Santander, Spain.; School of Medicine, University of Cantabria, Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2017 Jan 06; Vol. 7, pp. 40303. Date of Electronic Publication: 2017 Jan 06.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genetic Predisposition to Disease*
    Arthritis, Rheumatoid/*genetics
    Atherosclerosis/*complications
    Atherosclerosis/*genetics
    Coronary Artery Disease/*complications
    Coronary Artery Disease/*genetics
    Polymorphism, Single Nucleotide/*genetics
    Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Spain
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.
    Autorzy:
    Ortiz-Fernández L; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Carmona FD; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS Granada, Granada, 18016, Spain.
    Montes-Cano MA; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    García-Lozano JR; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Conde-Jaldón M; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Ortego-Centeno N; Department of Internal Medicine, Hospital Clínico San Cecilio, Granada, 18003, Spain.
    Castillo MJ; Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, 41003, Spain.
    Espinosa G; Department Autoimmune Diseases, Hospital Universitari Clínic, Barcelona, 08036, Spain.
    Graña-Gil G; Department of Rheumatology, Complejo Hospitalario Universitario A Coruña, A Coruña, 15006, Spain.
    Sánchez-Bursón J; Department of Rheumatology, Hospital Universitario de Valme, Sevilla, 41014, Spain.
    Juliá MR; Department of Immunology, Hospital Universitari Son Espases, Palma de Mallorca, 07120, Spain.
    Solans R; Department of Internal Medicine, Autoimmune Systemic Diseases Unit, Hospital Vall d'Hebron, Universidad Autonoma de Barcelona, Barcelona, 08035, Spain.
    Blanco R; Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain.
    Barnosi-Marín AC; Department of Internal Medicine, Complejo Hospitalario Torrecárdenas, Almería, 04009, Spain.
    Gómez de la Torre R; Department of Internal Medicine, Hospital Universitario Central de Asturias, Asturias, 33011, Spain.
    Fanlo P; Department of Internal Medicine, Hospital Virgen del Camino, Pamplona, 31008, Spain.
    Rodríguez-Carballeira M; Deparment of Internal Medicine, Hospital Universitari Mútua Terrassa, Terrassa, 08221, Spain.
    Rodríguez-Rodríguez L; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, 28040, Spain.
    Camps T; Department of Internal Medicine, Hospital Regional Universitario de Málaga, Málaga, 29010, Spain.
    Castañeda S; Department of Rheumatology, Hospital de la Princesa, IIS-Princesa, Madrid, 28006, Spain.
    Alegre-Sancho JJ; Department of Rheumatology, Hospital Universitario Doctor Peset, Valencia, 46017, Spain.
    Martín J; Instituto de Parasitología y Biomedicina 'López-Neyra', CSIC, PTS Granada, Granada, 18016, Spain.
    González-Escribano MF; Department of Immunology, Hospital Universitario Virgen del Rocío (IBiS, CSIC, US), Sevilla, 41013, Spain.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Aug 22; Vol. 11 (8), pp. e0161305. Date of Electronic Publication: 2016 Aug 22 (Print Publication: 2016).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Genetic Predisposition to Disease*
    Behcet Syndrome/*genetics
    Contactins/*genetics
    HLA-B51 Antigen/*genetics
    Interleukin-12 Subunit p35/*genetics
    Receptors, Interleukin/*genetics
    Alleles ; Behcet Syndrome/immunology ; Behcet Syndrome/pathology ; Case-Control Studies ; Contactins/immunology ; Gene Frequency ; Genetic Loci ; HLA-A3 Antigen/genetics ; HLA-A3 Antigen/immunology ; HLA-B Antigens/genetics ; HLA-B Antigens/immunology ; HLA-B51 Antigen/immunology ; Humans ; Immunoassay ; Interleukin-12 Subunit p35/immunology ; Logistic Models ; Microarray Analysis ; Models, Molecular ; Receptors, Interleukin/immunology ; Spain
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.
    Autorzy:
    López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Remuzgo-Martínez S; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    González-Juanatey C; Cardiology Department, Hospital Lucus Augusti, Lugo, Spain.
    Robustillo-Villarino M; Division of Rheumatology, Hospital Universitario Doctor Peset, Valencia, Spain.
    Llorca J; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
    Corrales A; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Vicente E; Division of Rheumatology, Hospital Universitario la Princesa, IIS-IPrincesa, Madrid, Spain.
    Miranda-Filloy JA; Rheumatology Department, Hospital Universitario Lucus Augusti, Lugo, Spain.
    Magro C; Division of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.
    Tejera-Segura B; Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
    Ramírez Huaranga MA; Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
    Pina T; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Alegre-Sancho JJ; Division of Rheumatology, Hospital Universitario Doctor Peset, Valencia, Spain.
    Raya E; Division of Rheumatology, Hospital Clínico San Cecilio, Granada, Spain.
    Mijares V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Ubilla B; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.
    Mínguez Sánchez MD; Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
    Gómez-Vaquero C; Department of Rheumatology, Hospital Universitario Bellvitge, Barcelona, Spain.
    Balsa A; Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain.
    Pascual-Salcedo D; Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain.
    López-Longo FJ; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    Carreira P; Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
    González-Álvaro I; Division of Rheumatology, Hospital Universitario la Princesa, IIS-IPrincesa, Madrid, Spain.
    Rodríguez-Rodríguez L; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
    Fernández-Gutiérrez B; Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain.
    Ferraz-Amaro I; Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
    Castañeda S; Division of Rheumatology, Hospital Universitario la Princesa, IIS-IPrincesa, Madrid, Spain.
    Martín J; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
    González-Gay MA; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Division of Rheumatology, IDIVAL, Santander, Spain.; School of Medicine, University of Cantabria, Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Aug 18; Vol. 6, pp. 31979. Date of Electronic Publication: 2016 Aug 18.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Arthritis, Rheumatoid/*blood
    Arthritis, Rheumatoid/*genetics
    Atherosclerosis/*blood
    Atherosclerosis/*genetics
    C-Reactive Protein/*genetics
    Cardiovascular Diseases/*blood
    Cardiovascular Diseases/*genetics
    Aged ; Arthritis, Rheumatoid/epidemiology ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/epidemiology ; Cardiovascular Diseases/diagnostic imaging ; Cardiovascular Diseases/epidemiology ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Genetic ; Risk Factors ; White People
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.
    Autorzy:
    López-Mejías R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Remuzgo-Martínez S; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Robustillo-Villarino M; Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
    García-Bermúdez M; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
    Llorca J; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
    Corrales A; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    González-Juanatey C; Cardiology Department, Hospital Lucus Augusti, Lugo, Spain.
    Ubilla B; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Miranda-Filloy JA; Rheumatology Department, Hospital Lucus Augusti, Lugo, Spain.
    Mijares V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Pina T; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.
    Alegre-Sancho JJ; Rheumatology Department, Hospital Universitario Doctor Peset, Valencia, Spain.
    Ramírez Huaranga MA; Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
    Mínguez Sánchez MD; Rheumatology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
    Tejera Segura B; Rheumatology Department, Hospital Universitario de Canarias, Tenerife, Spain.
    Ferraz-Amaro I; Rheumatology Department, Hospital Universitario de Canarias, Tenerife, Spain.
    Vicente E; Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain.
    Carmona FD; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
    Castañeda S; Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain.
    Martín J; Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain.
    González-Gay MA; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain.; Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Health Research Institute of Santiago de Compostela (IDIS), Division of Rheumatology, Clinical University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Nov 16; Vol. 10 (11), pp. e0143153. Date of Electronic Publication: 2015 Nov 16 (Print Publication: 2015).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Arthritis, Rheumatoid/*genetics
    Atherosclerosis/*genetics
    Interleukin-33/*genetics
    Adult ; Aged ; Alleles ; Arthritis, Rheumatoid/complications ; Atherosclerosis/etiology ; Carotid Arteries/diagnostic imaging ; Female ; Follow-Up Studies ; Gene Frequency ; Genotype ; Humans ; Linkage Disequilibrium ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Receptors, Interleukin-1 Type I/genetics ; Risk ; Ultrasonography
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy.
    Autorzy:
    Comín-Colet J; Department of Cardiology, Hospital Prínceps d'Espanya, Ciutat Sanitária i Universitária de Bellvitge, Barcelona, Spain. />Sánchez-Corral MA
    Alegre-Sancho JJ
    Valverde J
    López-Gómez D
    Sabaté X
    Juan-Mas A
    Esplugas E
    Pokaż więcej
    Źródło:
    Lupus [Lupus] 2001; Vol. 10 (1), pp. 59-62.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Heart Block/*etiology
    Lupus Erythematosus, Systemic/*complications
    Adolescent ; Adult ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/therapeutic use ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Lupus Erythematosus, Systemic/drug therapy ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies